Panagora Asset Management Inc Syros Pharmaceuticals, Inc. Transaction History

Panagora Asset Management Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 10, 2021	SELL	$4.08 - $5.66 $1,746 - $2,422	-428 Closed	0 $0
Q4 2020 Feb 10, 2021	BUY	$6.66 - $14.66 $2,850 - $6,274	428 New	428 $5,000
Q1 2019 May 15, 2019	SELL	$5.51 - $9.59 $519,075 - $903,435	-94,206 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$10.16 - $13.65 $957,132 - $1.29 Million	94,206 New	94,206 $962,000

Ticker SYRS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,236,200
Market Cap $43.1M
Description
Syros Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of treatments for cancer and monogenic diseases, and building a pipeline of gene control medicines. The company's lead product candidates are Tamibarotene, a selective retinoic acid receptor alpha agonist, which is in Phase III clinical trial for genomically def...

Get notified when there are updates to the investment portfolio of Panagora Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Panagora Asset Management Inc with notifications on news.